Israel Fernández Cadenas, principal investigator of the Pharmacogenomics and Neurovascular Genetics group of the Sant Pau Hospital Research Institute, has been elected Vice-Chair of the International Stroke Genetics Consortium (ISGC). The ISGC was created in 2007 and is currently made up of more than 200 researchers representing 20 countries from five continents. It is the main international consortium for the genetic study of stroke. This consortium has resulted in studies published in journals such as the New England Journal of Medicine, Nature Genetics or Lancet Neurology. This is the first time that a state researcher has been appointed vice-president of this consortium.
International Stroke Genetics Consortium (ISGC)
